Cm28 (R), n=6 cell(s)

Main group: Optic Lobe Intrinsic Neurons; Neurotransmitter consensus prediction: unclear

Mean synapse counts per layer

  LA
Post -
Pre -
  M1 M2 M3 M4 M5 M6 M7 M8 M9 M10 Total
0 - - - - 23.7 626.8 359.8 22.3 - - 1032.7
1 - - - - 16.2 276.5 69.0 2.5 - - 364.2
  LO1 LO2 LO3 LO4 LO5a LO5b LO6 Total
Post - - - - - - - -
Pre - - - - - - - -
  AME
0 5.7
1 2.3
  LOP1 LOP2 LOP3 LOP4 Total
Post - - - - -
Pre - - - - -
  central brain
0 -
1 -

Neuron visualizations

Population spatial coverage

Medulla

Number of post synapses: 6196

Number of pre synapses: 2185

Number of output connections: 6662

Coverage factor: 1.9

Columnar completeness: 0.89

Area completeness: 0.95

Cell size (columns): 194

Lobula

Number of post synapses: 0

Number of pre synapses: 0

Number of output connections: 0

Coverage factor: 0

Columnar completeness: 0

Area completeness: 0

Cell size (columns): 0

Lobula Plate

Number of post synapses: 0

Number of pre synapses: 0

Number of output connections: 0

Coverage factor: 0

Columnar completeness: 0

Area completeness: 0

Cell size (columns): 0

Optic Lobe Connectivity

Inputs

  instance NT total connections connections /#Cm28 (R) % % cumu.
0 Cm4 (R) Glu 1,540 256.7 25.4% 25.4%
1 MeTu3b (R) ACh 484 80.7 8.0% 33.4%
2 Dm2 (R) ACh 453 75.5 7.5% 40.8%
3 MeVP15 (R) ACh 336 56.0 5.5% 46.4%
4 MeTu3c (R) ACh 335 55.8 5.5% 51.9%
5 MeVPMe7 (L) Glu 334 55.7 5.5% 57.4%
6 Tm5a (R) ACh 291 48.5 4.8% 62.2%
7 MeVP14 (R) ACh 201 33.5 3.3% 65.5%
8 MeLo3b (R) ACh 166 27.7 2.7% 68.2%
9 Cm34 (R) Glu 139 23.2 2.3% 70.5%
10 Mi15 (R) ACh 135 22.5 2.2% 72.7%
11 MeVP1 (R) ACh 109 18.2 1.8% 74.5%
12 MeTu2a (R) ACh 99 16.5 1.6% 76.2%
13 Tm12 (R) ACh 91 15.2 1.5% 77.7%
14 Cm18 (R) Glu 85 14.2 1.4% 79.1%
15 MeLo5 (R) ACh 63 10.5 1.0% 80.1%
16 MeLo6 (R) ACh 56 9.3 0.9% 81.0%
17 MeVC27 (L) unclear 56 9.3 0.9% 82.0%
18 Dm9 (R) Glu 52 8.7 0.9% 82.8%
19 Cm10 (R) GABA 51 8.5 0.8% 83.7%
20 MeVPMe7 (R) Glu 50 8.3 0.8% 84.5%
21 Tm20 (R) ACh 39 6.5 0.6% 85.1%
22 MeVPMe13 (R) ACh 37 6.2 0.6% 85.7%
23 Cm33 (R) GABA 35 5.8 0.6% 86.3%
24 Cm9 (R) Glu 28 4.7 0.5% 86.8%
25 Dm-DRA1 (R) Glu 28 4.7 0.5% 87.2%
26 MeVP12 (R) ACh 28 4.7 0.5% 87.7%
27 Tm30 (R) GABA 26 4.3 0.4% 88.1%
28 Cm2 (R) ACh 25 4.2 0.4% 88.5%
29 Cm29 (R) GABA 23 3.8 0.4% 88.9%
30 Cm26 (R) Glu 20 3.3 0.3% 89.2%
31 Tm5c (R) Glu 20 3.3 0.3% 89.6%
32 Cm5 (R) GABA 19 3.2 0.3% 89.9%
33 Cm8 (R) GABA 19 3.2 0.3% 90.2%
34 HBeyelet (R) His 18 3.0 0.3% 90.5%
35 Tm34 (R) Glu 18 3.0 0.3% 90.8%
36 MeVPMe10 (L) Glu 17 2.8 0.3% 91.1%
37 Cm21 (R) GABA 16 2.7 0.3% 91.3%
38 Cm7 (R) Glu 15 2.5 0.2% 91.6%
39 TmY17 (R) ACh 15 2.5 0.2% 91.8%
40 MeTu3a (R) ACh 14 2.3 0.2% 92.1%
41 R7d (R) His 14 2.3 0.2% 92.3%
42 Cm1 (R) ACh 13 2.2 0.2% 92.5%
43 Cm3 (R) GABA 12 2.0 0.2% 92.7%
44 aMe5 (R) ACh 11 1.8 0.2% 92.9%
45 MeTu1 (R) ACh 11 1.8 0.2% 93.1%
46 MeVP38 (R) ACh 11 1.8 0.2% 93.2%
47 Cm14 (R) GABA 10 1.7 0.2% 93.4%
48 Mi10 (R) ACh 10 1.7 0.2% 93.6%
49 OA-AL2i4 (R) OA 10 1.7 0.2% 93.7%
50 Cm6 (R) GABA 9 1.5 0.1% 93.9%
51 MeTu2b (R) unclear 9 1.5 0.1% 94.0%
52 MeVP6 (R) Glu 9 1.5 0.1% 94.2%
53 Tm40 (R) ACh 9 1.5 0.1% 94.3%
54 aMe9 (R) ACh 8 1.3 0.1% 94.5%
55 MeVPLo2 (R) ACh 8 1.3 0.1% 94.6%
56 MeVPMe12 (R) ACh 8 1.3 0.1% 94.7%
57 aMe4 (R) ACh 7 1.2 0.1% 94.8%
58 Cm11a (R) ACh 7 1.2 0.1% 95.0%
59 Cm20 (R) GABA 7 1.2 0.1% 95.1%
60 Pm4 (R) GABA 7 1.2 0.1% 95.2%
61 Tm36 (R) ACh 7 1.2 0.1% 95.3%
62 TmY10 (R) ACh 7 1.2 0.1% 95.4%
63 TmY5a (R) Glu 7 1.2 0.1% 95.5%
64 Cm15 (R) GABA 6 1.0 0.1% 95.6%
65 Cm17 (R) GABA 6 1.0 0.1% 95.7%
66 Dm8b (R) Glu 6 1.0 0.1% 95.8%
67 MeTu4a (R) ACh 6 1.0 0.1% 95.9%
68 MeVP10 (R) ACh 6 1.0 0.1% 96.0%
69 MeVPMe13 (L) ACh 6 1.0 0.1% 96.1%
70 Tm29 (R) Glu 6 1.0 0.1% 96.2%
71 Tm5b (R) ACh 6 1.0 0.1% 96.3%

Outputs

  instance NT total connections connections /#Cm28 (R) % % cumu.
0 Cm11b (R) ACh 907 151.2 13.5% 13.5%
1 TmY10 (R) ACh 552 92.0 8.2% 21.7%
2 Cm11a (R) ACh 515 85.8 7.7% 29.4%
3 MeVPMe13 (R) ACh 357 59.5 5.3% 34.7%
4 Cm7 (R) Glu 318 53.0 4.7% 39.4%
5 Cm26 (R) Glu 267 44.5 4.0% 43.4%
6 Cm11c (R) ACh 266 44.3 4.0% 47.3%
7 Cm32 (R) GABA 213 35.5 3.2% 50.5%
8 Tm5a (R) ACh 199 33.2 3.0% 53.5%
9 Tm12 (R) ACh 191 31.8 2.8% 56.3%
10 Cm29 (R) GABA 160 26.7 2.4% 58.7%
11 aMe4 (R) ACh 149 24.8 2.2% 60.9%
12 Cm11d (R) ACh 147 24.5 2.2% 63.1%
13 Cm21 (R) GABA 143 23.8 2.1% 65.2%
14 MeVP15 (R) ACh 135 22.5 2.0% 67.2%
15 MeTu2b (R) unclear 132 22.0 2.0% 69.2%
16 MeVPMe13 (L) ACh 124 20.7 1.8% 71.0%
17 Cm17 (R) GABA 98 16.3 1.5% 72.5%
18 Cm18 (R) Glu 79 13.2 1.2% 73.6%
19 MeTu3c (R) ACh 73 12.2 1.1% 74.7%
20 Cm15 (R) GABA 68 11.3 1.0% 75.7%
21 Cm5 (R) GABA 68 11.3 1.0% 76.8%
22 Cm33 (R) GABA 64 10.7 1.0% 77.7%
23 Cm3 (R) GABA 58 9.7 0.9% 78.6%
24 Cm4 (R) Glu 55 9.2 0.8% 79.4%
25 TmY17 (R) ACh 52 8.7 0.8% 80.2%
26 Cm-DRA (R) ACh 51 8.5 0.8% 80.9%
27 Tm5b (R) ACh 51 8.5 0.8% 81.7%
28 MeVP7 (R) ACh 50 8.3 0.7% 82.4%
29 Dm8b (R) Glu 44 7.3 0.7% 83.1%
30 Cm19 (R) GABA 42 7.0 0.6% 83.7%
31 Tm20 (R) ACh 39 6.5 0.6% 84.3%
32 Cm10 (R) GABA 34 5.7 0.5% 84.8%
33 TmY21 (R) ACh 34 5.7 0.5% 85.3%
34 Cm2 (R) ACh 31 5.2 0.5% 85.8%
35 Dm20 (R) Glu 29 4.8 0.4% 86.2%
36 Cm8 (R) GABA 28 4.7 0.4% 86.6%
37 l-LNv (R) unclear 28 4.7 0.4% 87.0%
38 Tm5c (R) Glu 28 4.7 0.4% 87.4%
39 Dm-DRA1 (R) Glu 25 4.2 0.4% 87.8%
40 Cm1 (R) ACh 24 4.0 0.4% 88.2%
41 Cm31b (R) GABA 23 3.8 0.3% 88.5%
42 Dm2 (R) ACh 22 3.7 0.3% 88.8%
43 Tm5Y (R) ACh 22 3.7 0.3% 89.2%
44 MeTu3b (R) ACh 21 3.5 0.3% 89.5%
45 aMe2 (R) Glu 20 3.3 0.3% 89.8%
46 MeTu2a (R) ACh 19 3.2 0.3% 90.1%
47 Tm29 (R) Glu 18 3.0 0.3% 90.3%
48 Tm33 (R) ACh 18 3.0 0.3% 90.6%
49 Mi15 (R) ACh 16 2.7 0.2% 90.8%
50 Cm34 (R) Glu 15 2.5 0.2% 91.0%
51 MeVP12 (R) ACh 15 2.5 0.2% 91.3%
52 MeVPMe7 (L) Glu 15 2.5 0.2% 91.5%
53 Cm9 (R) Glu 14 2.3 0.2% 91.7%
54 Tm40 (R) ACh 14 2.3 0.2% 91.9%
55 Cm14 (R) GABA 12 2.0 0.2% 92.1%
56 Cm24 (R) Glu 12 2.0 0.2% 92.3%
57 Cm6 (R) GABA 12 2.0 0.2% 92.4%
58 MeVP1 (R) ACh 12 2.0 0.2% 92.6%
59 TmY18 (R) ACh 12 2.0 0.2% 92.8%
60 Cm31a (R) GABA 11 1.8 0.2% 93.0%
61 MeVP40 (R) unclear 11 1.8 0.2% 93.1%
62 aMe5 (R) ACh 10 1.7 0.1% 93.3%
63 MeVP2 (R) ACh 10 1.7 0.1% 93.4%
64 MeVP47 (R) unclear 10 1.7 0.1% 93.6%
65 MeVP6 (R) Glu 10 1.7 0.1% 93.7%
66 Mi17 (R) GABA 10 1.7 0.1% 93.9%
67 Tm37 (R) Glu 10 1.7 0.1% 94.0%
68 aMe12 (R) ACh 9 1.5 0.1% 94.2%
69 Cm20 (R) GABA 9 1.5 0.1% 94.3%
70 Dm8a (R) Glu 9 1.5 0.1% 94.4%
71 MeLo3b (R) ACh 9 1.5 0.1% 94.6%
72 MeTu1 (R) ACh 9 1.5 0.1% 94.7%
73 MeTu3a (R) ACh 9 1.5 0.1% 94.8%
74 MeVPLo2 (R) ACh 9 1.5 0.1% 95.0%
75 Mi16 (R) GABA 9 1.5 0.1% 95.1%
76 Mi2 (R) Glu 9 1.5 0.1% 95.2%
77 Tm31 (R) Glu 9 1.5 0.1% 95.4%
78 Tm38 (R) ACh 9 1.5 0.1% 95.5%
79 aMe9 (R) ACh 8 1.3 0.1% 95.6%
80 Tm39 (R) ACh 8 1.3 0.1% 95.7%
81 TmY5a (R) Glu 8 1.3 0.1% 95.9%
82 Dm9 (R) Glu 7 1.2 0.1% 96.0%
83 ME_unclear (R) ACh 7 1.2 0.1% 96.1%
84 MeVP10 (R) ACh 7 1.2 0.1% 96.2%
85 MeVPMe3 (R) Glu 7 1.2 0.1% 96.3%
86 Tm3 (R) ACh 7 1.2 0.1% 96.4%
87 Cm13 (R) Glu 6 1.0 0.1% 96.5%
88 Cm22 (R) GABA 6 1.0 0.1% 96.5%
89 Tm34 (R) Glu 6 1.0 0.1% 96.6%